Norway Oncoinvent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation.
Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Funding Round
June 29, 2021 GMT
OSLO, Norway (BUSINESS WIRE) Jun 29, 2021
Norway Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, announced today that the company has raised NOK 250 million in an oversubscribed pre-IPO financing round syndicated by existing investors Hadean Ventures, Geveran, RADFORSK Investeringsstiftelse, Sundt, Must Invest, Canica, MP Pensjon and Watrium. The net proceeds from the Private Placement are expected to ensure financing past end of 2023 for its lead product candidate Radspherin®, including financing of two clinical phase 2A studies (in ovarian cancer and colorectal cancer) as well as the advancement of the company’s proprietary targeted radiotherapy candidates. Oncoinvent has raised a total of NOK 535 mi ....

Jana Alfheim , Courtney Turiano , Royh Larsen , Ingrid Teigland Akay , Linear Energy Transfer , Hadean Ventures , Must Invest , Private Placement , Board Chair , Teigland Akay , Managing Partner , Chief Executive , Stern Investor , Norway Oncoinvent , Business Wire , நேரியல் ஆற்றல் பரிமாற்றம் , வேண்டும் முதலீடு , ப்ரைவேட் வேலை வாய்ப்பு , பலகை நாற்காலி , நிர்வகித்தல் கூட்டாளர் , தலைமை நிர்வாகி , கடுமையான முதலீட்டாளர் , வணிக கம்பி ,